| PERIOD ENDING | 5-Jul-09 | 5-Apr-09 | 28-Dec-08 | 28-Sep-08 | | Total Revenue | 434,575 | 431,574 | 421,369 | 505,117 | | Cost of Revenue | 247,102 | 243,619 | 219,641 | 293,957 | | | Gross Profit | 187,473 | 187,955 | 201,728 | 211,160 | | | Operating Expenses | | Research Development | 25,568 | 25,973 | 21,528 | 27,526 | | Selling General and Administrative | 123,962 | 128,414 | 116,666 | 131,118 | | Non Recurring |
-
| 7,823 | (719) | 7,214 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 37,943 | 25,745 | 64,253 | 45,302 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48 | (249) | (22,514) | 321 | | Earnings Before Interest And Taxes | 37,991 | 25,496 | 41,739 | 45,623 | | Interest Expense | 4,229 | 4,588 | 6,787 | 6,371 | | Income Before Tax | 33,762 | 20,908 | 34,952 | 39,252 | | Income Tax Expense | 10,807 | 5,847 | 7,734 | (4,506) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,955 | 15,061 | 27,218 | 43,758 | | | Non-recurring Events | | Discontinued Operations | (1,450) | (4,502) | 3,445 | 8,144 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,505 | 10,559 | 30,663 | 51,902 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,505 | $10,559 | $30,663 | $51,902 |
|
2.03% Nasdaq 
Income Statement
